ISID Home
about ISID | membership | programs | publications | resources | 14th ICID | site map
 
ProMed Home
 
  Navigation
Home
Subscribe/Unsubscribe
Search Archives
Announcements
Recalls/Alerts
Calendar of Events
Maps of Outbreaks
Submit Info
FAQs
Who's Who
Awards
Citing ProMED-mail
Links
Donations
About ProMED-mail
 
Archive Number 20091121.4006
Published Date 21-NOV-2009
Subject PRO/AH/EDR> African swine fever - Russia (13): (ST) update, review

AFRICAN SWINE FEVER - RUSSIA (13): (STAVROPOL) UPDATE, REVIEW
*************************************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Mon 16 Nov 2009
Source: Rosbalt Information Agency [in Russian, trans. Corr.ATS, edited]
<http://www.rosbalt.ru/2009/11/16/689242.html>


The swine populations are being culled in the 
village of Bogdanovka in Stepnsovsky district and 
in the farmstead Novoivanovsky of Kursky district 
[Stavropol krai (territory)]. The press service 
of the territory's governor has informed 
"Rosbalt" that these measures are being taken 
because of cases of African swine fever. The 
virus was detected in the pork brought from 
Novoivanovsky to Bogdanovka. Quarantine measures 
are now being implemented in both settlements. 
The sick animal had been bought from North 
Ossetia. The attorney's office is carrying out an 
investigation around this incident. The governor 
of the territory announced that those who are 
found violating veterinary rules will not be 
reimbursed for culled animals and even criminal 
charges might be applied upon malicious rule 
breakers. As a reminder, an outbreak of ASF was 
registered in North Ossetia in November. 
Quarantine measures are also in place in Rostov 
oblast and Kalimikia because of ASF outbreaks during this Fall (2009).

--
Communicated by:
ProMED-RUS
<promed-rus@promedmail.org>

[Stavropol krai (territory) can be located on the map at
<http://en.wikipedia.org/wiki/File:Map_of_Russia_-_Stavropol_Krai_(2008-03).svg>.
The HealthMap/ProMED-mail interactive map of Russia is available at
<http://healthmap.org/r/00-T>.

Russia has submitted to the OIE its 10th 
follow-up report on ASF on 19 Nov 2009, notifying 
2 new outbreaks in domestic pig holdings in 2 
hamlets, Antonov and Troytsky in the Rostov 
region. The current Russian epizootic started 26 
Sep 2009, so far involving 26 outbreaks. See, 
including map with the 26 outbreaks in domestic 
and wild swine, at 
<http://www.oie.int/wahis/public.php?page=event_summary&reportid=8462>.

The recent outbreaks in Georgia and the 
subsequent spread of the disease to Armenia, 
Azerbaijan, and Russia are of great concern to 
the growing pig industry in many eastern European 
countries. The situation has been further 
complicated and control options made more 
difficult by the spread of the disease into the 
local wild boar populations. Further west- or 
eastward spread could adversely affect the pig 
sector in many countries. For instance, the pig 
industry in the Ukraine is an important growing 
agricultural sector with massive foreign 
investments into large-scale pig farming. The 
presence of wild boar could lead to spread of ASF 
to Moldova, Romania, Hungary, Slovakia, Poland, or Belarus.

The 1st spread of ASF outside Africa was to 
Portugal in 1957 as a result of waste from 
airline flights being fed to pigs near Lisbon 
airport. Although this incursion of disease was 
eradicated, a further outbreak occurred in 1960 
in Lisbon and ASF then spread to Spain and 
remained endemic in the Iberian peninsula until the mid 1990s.

Outbreaks of ASF were reported subsequently in a 
number of other European countries, including 
Malta (1978), Italy (1967, 1980), France (1964, 
1967, 1977), Belgium (1985), and The Netherlands 
in 1986. The disease was eradicated from each of 
these countries but in Sardinia it has remained 
endemic since its introduction in 1982. In Spain, 
the final 5 years of the eradication programme 
alone were estimated to have cost USD 92 million; 
the disease was eventually eradicated in 1994.

Cuba, in 1971, was the 1st country in the 
Caribbean region to report infection with ASF, 
and the virus was believed to have been 
introduced from Spain. ASF was further reported 
in the late 1970s in several Caribbean island 
countries: Cuba (1978, date of last occurrence 
1980), Dominican Republic (1978, date of last 
occurrence 1981), and Haiti (1979, date of last 
occurrence 1984). ASF was reported in Brazil in 
1978 and was probably introduced from Spain or 
Portugal through food waste carried by 
transcontinental flights and/or animal products 
imported by tourists. The date of the last reported occurrence was 1981.

An updated review, "African swine fever: how can 
global spread be prevented?" was published on 27 
Sep 2009 in Phil. Trans. R. Soc. B 2009 364, 
2683-2696. The review was authored by scientists 
from leading institutions in UK, France, 
Australia, and Kenya (S Costard, B Wieland, W de 
Glanville, F Jori, R Rowlands, W Vosloo, F Roger, DU Pfeiffer, and LK Dixon).

The following 2 final chapters of the review, 
nos. 7 and 8, may be found useful by subscribers.

7. Vaccine development
----------------------
There is currently no vaccine available for ASFV, 
although there is no doubt that this is feasible. 
Protection can be achieved by inoculation of pigs 
with low-virulence isolates obtained by passage 
in tissue culture or by deletion of genes 
involved in virulence, as well as low-virulence 
isolates from the field (Lewis et al. 2000; 
Leitao et al. 2001; Boinas et al. 2004).

The mechanism of protection involves 
cell-mediated immunity, since depletion of CD8þ T 
cells abrogates protection (Oura et al. 2005; 
Denyer et al. 2006). A role for antibodies in 
protection is also suggested since passive 
transfer of antibodies from immune pigs conferred 
partial protection to lethal challenge (Onisk et 
al. 1994). In experiments using recombinant 
proteins, partial protection was achieved using a 
combination of 2 proteins, p54 and p30, as well 
as with recombinant CD2-like protein 
(Ruiz-Gonzalvo et al. 1996; Gomez-Puertas et al. 
1998). The failure to achieve complete protection 
in these experiments may be because of the 
delivery method of the antigens and/or because 
more or different antigens are required to confer protection.

Further research is required to develop effective 
vaccines. Identification of ASFV genes involved 
in virulence and in evasion of the host's immune 
response (for review see Dixon et al. 2008) makes 
the development of rationally attenuated vaccines 
through sequential deletion of these genes 
realistic. However, extensive testing of the 
safety of such vaccines is required before their 
use in the field. An alternative safer approach 
would involve the development of defective 
non-replicating ASFV vaccines. These approaches 
have the advantage that many antigens are 
expressed and no prior knowledge of which are 
protective is required; however, high containment 
facilities are required for vaccine production.

Alternative approaches based on expression of 
protective antigens are feasible but first 
require identification of those antigens. The 
development of high-throughput methods for 
constructing recombinant viral vectors opens a 
route for global analysis of the protective 
potential of all ASFV-expressed genes. One 
concern about the use of ASFV vaccines is the 
genetic diversity of strains circulating in some 
countries. Recent experiments have demonstrated 
cross-protection between different genotypes and 
therefore it may be possible to develop vaccines, 
which can cross-protect against infection with 
several genotypes. Moreover, in some regions 
isolates of just one genotype are circulating. 
These include countries in West and central 
Africa (genotype I), the large endemic region 
including Malawi and Zambia (genotype VIII) and 
the Caucasus and Russia (genotype II).

8. Preventing global spread
---------------------------
The review of the current situation in endemic 
regions, including insights gained through 
molecular epidemiology and lessons learnt from 
past outbreaks in non-endemic areas, highlight 
the complexity of ASF epidemiology. To combat ASF 
globally, surveillance and control need to be managed at 3 levels:
(i) locally at points of occurrence;
(ii) at regional level in endemic and adjoining areas; and
(iii) globally by preventing transboundary and 
transcontinental spread through animal movement and products.

In the absence of an effective vaccine, direct 
and indirect pig-to-pig transmission and contact 
with wildlife reservoirs need to be limited in 
endemic areas to reduce disease burden. 
Increasing early detection would also improve the 
chances of disease control measures making them 
more effective. International agencies and donors 
should promote local capacity development, 
research activities including risk assessment, 
and regional coordination of emerging swine 
disease surveillance including ASF. For the 
implementation of control programmes in endemic 
or epidemic areas, tools for rapid detection 
would allow a timely diagnosis and ensure 
involvement at the local level in control. 
Lateral flow devices for detecting virus antigens 
have been used successfully in the global 
rinderpest eradication programme and have the 
potential for use in ASFV control. Other 
technologies including pen-side PCR tests could 
be used, although the equipment required may be more expensive.

Capacity building is also required to improve the 
ability of regional and national laboratories to 
confirm suspicious cases and to assist surveillance activities.

For local control in countries with a large 
small-scale pig-holder population, educational 
programmes to increase disease awareness and 
improved access to animal health services are 
required. In countries where the disease is 
endemic, where most pig owners are poor 
smallholders and where veterinary services lack 
resources to achieve compliance with regulations, 
the involvement of farmers is essential in the 
development of control strategies that will be 
applied effectively. In order to eradicate the 
disease in endemic areas, the role of wildlife 
reservoirs needs to be further investigated, 
including wild suids in Africa and wild boar in 
Sardinia and in the Caucasus. The distribution of 
_Ornithodoros_ species in the Caucasus region and 
their capacity to act as vectors for ASFV also needs to be investigated.

The feasibility of creating ASF-free zones within 
an endemic area was shown in South Africa and 
should serve as an example for localized disease 
eradication and prevention that will benefit 
trade, and thereby generate incentives for 
producers to support large-scale eradication 
programmes. Achieving ASF freedom is only 
realistic when all stakeholders perceive clear 
benefits from such a status and therefore are 
likely to comply with the necessary prevention 
and control measures. Effective communication and 
involvement of all stakeholders at each stage of 
the process together with the support of national 
and international veterinary authorities is 
pivotal to the success of such programmes.

To prevent the spread of ASF at global level 
through movement of livestock, countries are 
advised to follow international standards as 
outlined by the World Organization for Animal 
Health OIE. Strict regulations regarding animal 
by-products have proven effective in many 
developed countries and are critical given the 
high tenacity of the virus in meat products and 
in the environment. This has also been recognized 
by many developing countries. For example, 
following FMD outbreaks, the Philippines 
implemented an effective policy incorporating 
quarantine and control of waste food from ships and planes.

Comprehensive risk assessments are needed for all 
currently free countries with pig production 
relevant to farmers’ livelihoods in order to 
identify which introduction pathways are most 
important and inform-targeted or risk-based 
surveillance strategies. Risk assessments are 
also needed in endemic countries to identify the 
main mechanisms for spread in the pig production 
chain and thus target control measures 
effectively. Data required for such risk 
assessments include density and geographical 
distribution of susceptible animal species -- 
including feral and wild pigs -- and any relevant 
arthropod vectors, as well as the structure of 
the pig production and marketing sector at 
national and regional level. The effectiveness of 
surveillance systems, early warning and early 
response capacity, existing policies for 
test-and-slaughter, and other preventive measures 
need to be assessed. The level of international 
cooperation, political, commercial, and 
tourism-related links are also important, as are 
the level of economic development and other 
issues such as cultural and religious events that 
may influence trade patterns. Data indicating 
potential sources of infection (such as, ASF 
prevalence in export countries) should take into 
account the under-reporting of ASF outbreaks in 
endemic countries, in some cases associated with 
the economic development level of a country or political factors.

Lessons learnt from previous outbreaks and from 
outbreaks of similar diseases such as CSF in many 
countries worldwide should be considered when 
designing control programmes. Improved 
effectiveness of control also includes the need 
for continued research aimed at the development 
of an effective vaccine, since this may well have 
to be used together with other prevention and 
control measures in endemically affected countries.

For the references, and for the other 6 chapters 
of the Review, subscribers are referred to the original paper, available at
<http://rstb.royalsocietypublishing.org/content/364/1530/2683.abstract> 
(abstract free; full article upon subscription). - Mod.AS]

[see also:
African swine fever - Russia (12): (RO) update 20091110.3897
African swine fever - Russia (11): (LN, RO) OIE, FAO 20091027.3720
African swine fever - Russia (10): (KV), susp., RFI 20091020.3611
African swine fever - Russia (09): (KL), Ukraine avoids 20091017.3569
African swine fever - Russia (07): (DA, RO) 20091009.3494
African swine fever - Russia (06): (DA), OIE 20090926.3371
African swine fever - Russia (05): (RO) 20090410.1376
African swine fever - Russia (04): (STA) 20090328.1203
African swine fever - Russia (03): (STA) 20090319.1102
African swine fever - Russia (02): (STA,KDA) 20090117.0192
African swine fever - Russia: (STA) 20090113.0139
2008
----
African swine fever - Russia (10): (KDA, IN), OIE, (STA) 20081114.3596
African swine fever - Russia (09): (STA), clarification 20081104.3475
African swine fever - Russia (08): (STA), stamping out 20081030.3418
African swine fever - Russia (07): (Stavropol) OIE 20081025.3372
2007
----
African swine fever - Georgia, Armenia: FAO 20071004.3275
African swine fever - Armenia (05) 20071231.4195
African swine fever - Armenia (04): (Ararat) 20071213.4013
African swine fever - Armenia (03) 20071021.3430
African swine fever - Georgia, Armenia: FAO 20071004.3275
African swine fever - Armenia (02) 20070922.3150
African swine fever - Georgia (11): SDC mission report 20070920.3131
African swine fever - Georgia (10): Abkhazia Auton. Rep. 20070821.2737
African swine fever - Georgia (09): OIE 20070820.2724
African swine fever - Georgia (08) 20070817.2689
African swine fever - Georgia (07): EC/FAO/OIE 20070627.2066
African swine fever - Georgia (06) 20070615.1954
African swine fever - Georgia (05) 20070611.1901
African swine fever - Georgia (04): FAO 20070610.1891
African swine fever - Georgia (03): genotype 20070609.1886
African swine fever - Georgia (02): OIE 20070608.1860
African swine fever - Georgia: OIE 20070607.1845]
...................................ats/arn/mj/dk

*##########################################################*
************************************************************
ProMED-mail makes every effort to  verify  the reports  that
are  posted,  but  the  accuracy  and  completeness  of  the
information,   and  of  any  statements  or  opinions  based
thereon, are not guaranteed. The reader assumes all risks in
using information posted or archived by  ProMED-mail.   ISID
and  its  associated  service  providers  shall not be  held
responsible for errors or omissions or  held liable for  any
damages incurred as a result of use or reliance upon  posted
or archived material.
************************************************************
Become     a    ProMED-mail    Premium     Subscriber     at
<http://www.isid.org/ProMEDMail_Premium.shtml>
************************************************************
Visit ProMED-mail's web site at <http://www.promedmail.org>.
Send  all  items  for   posting  to:   promed@promedmail.org

(NOT to  an  individual moderator).  If you do not give your
full name and  affiliation, it  may  not  be  posted.   Send
commands  to  subscribe/unsubscribe,   get  archives,  help,
etc. to: majordomo@promedmail.org.    For assistance  from a
human  being  send  mail  to:   owner-promed@promedmail.org.

############################################################
############################################################

about ISID | membership | programs | publications | resources
14th ICID | site map | ISID home

©2001,2009 International Society for Infectious Diseases
All Rights Reserved.
Read our privacy guidelines.
Use of this web site and related services is governed by the Terms of Service.